YCBD

SEC source: 0001654954-21-002856 · section16.xml · derivative · entry 6

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: common stock · 30,000 shares

Expires 2026-03-11

SEC source: 0001654954-21-002856 · section16.xml · derivative · entry 5

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2022-03-12

SEC source: 0001654954-21-002856 · section16.xml · derivative · entry 4

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-12-31

SEC source: 0001654954-21-002856 · section16.xml · derivative · entry 3

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-09-30

SEC source: 0001654954-21-002856 · section16.xml · derivative · entry 2

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-06-30

SEC source: 0001654954-21-002856 · section16.xml · derivative · entry 1

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: common stock · 2,000 shares

Expires 2021-03-12

SEC source: 0001654954-21-002852 · section16.xml · derivative · entry 5

Stephen Scott G. · CIK 0001773957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: common stock · 30,000 shares

Expires 2026-03-11

SEC source: 0001654954-21-002852 · section16.xml · derivative · entry 4

Stephen Scott G. · CIK 0001773957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2022-03-12

SEC source: 0001654954-21-002852 · section16.xml · derivative · entry 3

Stephen Scott G. · CIK 0001773957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-12-31

SEC source: 0001654954-21-002852 · section16.xml · derivative · entry 2

Stephen Scott G. · CIK 0001773957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-09-30

SEC source: 0001654954-21-002852 · section16.xml · derivative · entry 1

Stephen Scott G. · CIK 0001773957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-06-30

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 6

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: common stock · 30,000 shares

Expires 2026-03-11

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 5

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2022-03-12

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 4

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-12-31

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 3

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-09-30

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 2

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-06-30

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,775,924

F1 · shares: Under the terms of the Agreement and Plan of Merger dated December 3, 2018 (the "Merger Agreement") and the related Voting Proxy dated December 20, 2018 (the "Voting Proxy"), the independent Chairman of the Audit Committee of the Issuer's Board of Directors held voting rights over an aggregate of 8,750,000 shares of common stock (the "Second Tranche Shares") initially issued to CBD Holding, LLC ("CBDH") until the unrestricted voting rights to those shares vest pursuant to the terms of the Merger Agreement. On December 20, 2019 the unrestricted voting rights to the first 2,187,500 shares vested. On February 26, 2020, in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, the CBDH members entered into similar Voting Proxy agreements with the Issuer. Until the unrestricted voting rights vest, Mr. Raines, as independent Chairman of the Audit Committee of the Issuer's Board of Directors, holds voting rights over these shares and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors. The Voting Proxy does not prohibit the shareholder from disposing of any portion of the Second Tranche Shares for which unrestricted voting rights have not yet vested. The dispositions by the Reporting Person reported in this Form 4 represents Second Tranche Shares which were subject to the Voting Proxy that were held by non-affiliates of the Issuer for which Rule 144 legend removals were requested and processed and, accordingly, are no longer subject to Voting Proxy agreements.

F2 · ownership.nature: The number of shares of common stock beneficially owned by the Reporting Person includes (i) 1,342 shares held by him directly; (ii) 92,582 shares held of record by Board Investor Group II, LLC; and (iii) 3,682,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 3,682,000 Second Tranche Shares which are subject to the Voting Proxy agreements. See footnote 1.

SEC source: 0001654954-21-010808 · section16.xml · nonDerivative · entry 1

Farar Sim · CIK 0001851461 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest as follows: 2,000 vested on March 12, 2021 and the remaining 5,000 vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-010810 · section16.xml · nonDerivative · entry 1

Stephen Scott G. · CIK 0001773957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,052

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-010809 · section16.xml · nonDerivative · entry 1

Sellers Bakari T. · CIK 0001721556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,531

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-010807 · section16.xml · nonDerivative · entry 1

Ghiloni Peter J. · CIK 0001773696 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,000

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-010802 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,342

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002741 · section16.xml · nonDerivative · entry 2

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,425,344

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by the Sumichrast 2017 Family Trust (the "Family Trust"). The Reporting Person has voting and dispositive control over securities owned of record by the Family Trust. The Reporting Person disclaims beneficial ownership of the securities held of record by this entity except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to dispose of the shares of common stock held of record by the Family Trust. The Reporting Person has the sole right to vote 1,031,594 shares of common stock held by the Family Trust and the balance of 393,750 shares are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Family Trust pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors. The voting rights to the 393,750 shares vest in equal portions on each of June 20, 2022 and December 20, 2023.

SEC source: 0001654954-21-002741 · section16.xml · nonDerivative · entry 1

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,490,837

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by the Sumichrast 2017 Family Trust (the "Family Trust"). The Reporting Person has voting and dispositive control over securities owned of record by the Family Trust. The Reporting Person disclaims beneficial ownership of the securities held of record by this entity except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to dispose of the shares of common stock held of record by the Family Trust. The Reporting Person has the sole right to vote 1,031,594 shares of common stock held by the Family Trust and the balance of 393,750 shares are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Family Trust pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors. The voting rights to the 393,750 shares vest in equal portions on each of June 20, 2022 and December 20, 2023.

SEC source: 0001654954-21-002572 · section16.xml · nonDerivative · entry 1

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,550,344

F1 · kind: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the "Closing Date"), CBD Holding, LLC ("CBDH"), then the sole member of Cure Based Development, LLC, was entitled to receive (the "Earnout Rights") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the "Earnout Shares") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months (the "Second Marking Period"), 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including the Sumichrast 2017 Family Trust ("Family Trust"), on a pro rata basis. On March 8, 2021 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the Second Marking Period had been achieved and the Issuer issued an aggregate of 3,348,250 shares of its common stock representing the Second Marking Period Earnout Shares which were earned under the terms of the Merger Agreement. Included in this issuance was the issuance of 301,343 Earnout Shares to the Family Trust.

F1 · price: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the "Closing Date"), CBD Holding, LLC ("CBDH"), then the sole member of Cure Based Development, LLC, was entitled to receive (the "Earnout Rights") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the "Earnout Shares") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months (the "Second Marking Period"), 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including the Sumichrast 2017 Family Trust ("Family Trust"), on a pro rata basis. On March 8, 2021 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the Second Marking Period had been achieved and the Issuer issued an aggregate of 3,348,250 shares of its common stock representing the Second Marking Period Earnout Shares which were earned under the terms of the Merger Agreement. Included in this issuance was the issuance of 301,343 Earnout Shares to the Family Trust.

F2 · ownership.nature: Represents shares of common stock that are held of record by the Family Trust. The Reporting Person has the sole power to dispose of the shares of common stock held of record by the Family Trust. The Reporting Person has the sole right to vote 1,156,594 shares of common stock held by the Family Trust and the balance of 393,750 shares are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Family Trust pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors. The voting rights to the 393,750 shares vest in equal portions on each of June 20, 2022 and December 20, 2023. The Reporting Person disclaims beneficial ownership of the securities held of record by the Family Trust except to the extent of his pecuniary interest therein.

SEC source: 0001654954-21-002571 · section16.xml · nonDerivative · entry 1

Coffman Raymond Scott · CIK 0001761772 · Director · CO-CEO, President, Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 14,990,896

F1 · kind: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the "Closing Date"), CBD Holding, LLC ("CBDH"), then the sole member of Cure Based Development, LLC, was entitled to receive (the "Earnout Rights") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the "Earnout Shares") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months (the "Second Marking Period"), 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC ("Coffman Family Office"), on a pro rata basis. On March 8, 2021 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the Second Marking Period had been achieved and the Issuer issued an aggregate of 3,348,250 shares of its common stock representing the Second Marking Period Earnout Shares which were earned under the terms of the Merger Agreement. Included in this issuance was the issuance of 2,196,126 Earnout Shares to Coffman Family Office.

F1 · price: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the "Closing Date"), CBD Holding, LLC ("CBDH"), then the sole member of Cure Based Development, LLC, was entitled to receive (the "Earnout Rights") up to 15,250,000 additional shares of the Issuer's common stock for no additional consideration (the "Earnout Shares") as part of the merger consideration, which such Earnout Shares were to be issued upon the satisfaction of certain aggregate net revenue criteria within 60 months following the Closing Date, as measured at four intervals from the Closing Date of 12 calendar months, 24 calendar months (the "Second Marking Period"), 42 calendar months, and 59 calendar months. The issuance of the Earnout Shares was approved by the Issuer's shareholders in April 2019. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, CBDH distributed the Earnout Rights to its members, including Coffman Family Office, LLC ("Coffman Family Office"), on a pro rata basis. On March 8, 2021 in accordance with the terms of the Merger Agreement the Issuer determined that the net revenue criteria for the Second Marking Period had been achieved and the Issuer issued an aggregate of 3,348,250 shares of its common stock representing the Second Marking Period Earnout Shares which were earned under the terms of the Merger Agreement. Included in this issuance was the issuance of 2,196,126 Earnout Shares to Coffman Family Office.

F2 · ownership.nature: Includes (i) 3,684,000 shares held of record by Edge of Business, LLC ("Edge of Business"); and (ii) 11,306,896 shares held of record by the Coffman Family Office. The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein. The Reporting Person has the sole power to vote and dispose of all of the shares of common stock held of record by Edge of Business. Coffman Management, LLC ("Coffman Management") is the Manager of the Coffman Family Office and the Reporting Person is the Manager of Coffman Management. The Reporting Person has sole power to dispose of all shares of common stock held by the Coffman Family Office and sole right to vote 8,434,708 shares of common stock held by the Coffman Family Office. The balance of 2,872,188 shares of common stock held of record by the Coffman Family Office are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Coffman Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors. The voting rights to the 2,872,188 shares vest in equal portions on each of June 20, 2022 and December 20, 2023.

SEC source: 0001654954-21-002293 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,342

SEC source: 0001654954-21-002011 · section16.xml · nonDerivative · entry 2

Coffman Raymond Scott · CIK 0001761772 · Director · CO-CEO, President, Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001654954-21-001934 · section16.xml · nonDerivative · entry 3

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by SFTI, LLC. The Reporting Person in his position at SFTI, LLC has the right to direct the vote and disposition of securities owned by SFTI, LLC. The Reporting Person disclaims beneficial ownership of the securities held of record by SFTI, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001654954-21-002011 · section16.xml · nonDerivative · entry 1

Coffman Raymond Scott · CIK 0001761772 · Director · CO-CEO, President, Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,000

SEC source: 0001654954-21-002522 · section16.xml · nonDerivative · entry 3

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by SFTI, LLC. The Reporting Person in his position at SFTI, LLC has the right to direct the vote and disposition of securities owned by SFTI, LLC. The Reporting Person disclaims beneficial ownership of the securities held of record by SFTI, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001654954-21-001934 · section16.xml · nonDerivative · entry 2

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 240,035

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by SFTI, LLC. The Reporting Person in his position at SFTI, LLC has the right to direct the vote and disposition of securities owned by SFTI, LLC. The Reporting Person disclaims beneficial ownership of the securities held of record by SFTI, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001654954-21-002522 · section16.xml · nonDerivative · entry 2

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 240,035

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by SFTI, LLC. The Reporting Person in his position at SFTI, LLC has the right to direct the vote and disposition of securities owned by SFTI, LLC. The Reporting Person disclaims beneficial ownership of the securities held of record by SFTI, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001654954-21-001934 · section16.xml · nonDerivative · entry 1

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 353,139

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by SFTI, LLC. The Reporting Person in his position at SFTI, LLC has the right to direct the vote and disposition of securities owned by SFTI, LLC. The Reporting Person disclaims beneficial ownership of the securities held of record by SFTI, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001654954-21-002522 · section16.xml · nonDerivative · entry 1

Sumichrast Martin A. · CIK 0001427722 · Director · Chairman & CO-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 353,139

F1 · ownership.nature: The number of shares of common stock sold by the Reporting Person in the reported transactions were owned of record by SFTI, LLC. The Reporting Person in his position at SFTI, LLC has the right to direct the vote and disposition of securities owned by SFTI, LLC. The Reporting Person disclaims beneficial ownership of the securities held of record by SFTI, LLC except to the extent of his pecuniary interest therein.

SEC source: 0001654954-20-013847 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 4,488,924

F1 · ownership.nature: Under the terms of the Agreement and Plan of Merger dated December 3, 2018 (the "Merger Agreement") and the related Voting Proxy dated December 20, 2018 (the "Voting Proxy"), the independent Chairman of the Audit Committee of the Issuer's Board of Directors held voting rights over an aggregate of 8,750,000 shares of common stock (the "Second Tranche Shares") initially issued to CBD Holding, LLC ("CBDH") until the unrestricted voting rights to those shares vest pursuant to the terms of the Merger Agreement. On December 20, 2019 the unrestricted voting rights to the first 2,187,500 shares vested. On February 26, 2020, in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the "CBDH Distribution Agreement"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis. On February 26, 2020, in connection with the CBDH Distribution Agreement, the CBDH members entered into similar Voting Proxy Agreements with the Issuer. On December 20, 2020 the unrestricted voting rights to an additional 2,187,5000 Second Tranche Shares vested pursuant to the terms of the Merger Agreement. The unrestricted voting rights to the remaining4,375,000 Second Tranche Shares will vest as follows: (i) 2,187,500 shares will vest on June 20, 2022; and (ii) the remaining 2,187,500 shares will vest on December 20, 2023. Until the unrestricted voting rights vest, Mr. Raines, as independent Chairman of the Audit Committee of the Issuer's Board of Directors, holds voting rights over these shares and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors. Mr. Raines disclaims beneficial ownership of the securities held of record by the CBDH members.

F2 · ownership.nature: The number of shares of common stock beneficially owned by Mr. Raines includes (i) 21,342 shares held by him directly; (ii) 92,582 shares held of record by Board Investor Group II, LLC; and (iii) 4,375,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 4,375,000 Second Tranche Shares which are subject to the Voting Proxy Agreements. See footnote 1.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 12

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,666

Underlying: Common stock · 41,666 shares

Expires 2028-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 11

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2027-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 10

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2026-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 9

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,666

Underlying: Common stock · 41,666 shares

Expires 2028-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 8

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2027-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 7

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common stock · 41,667 shares

Expires 2026-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 6

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common stock · 33,333 shares

Expires 2028-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 5

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common stock · 33,333 shares

Expires 2027-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 4

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,334

Underlying: Common stock · 33,334 shares

Expires 2026-10-01

F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 3

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common stock · 16,666 shares

Expires 2023-10-01

F3 · security: RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2023 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 2

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common stock · 16,667 shares

Expires 2022-10-01

F2 · security: RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2022 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010735 · section16.xml · derivative · entry 1

Kennedy Thomas Ronan · CIK 0001826452 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common stock · 16,667 shares

Expires 2021-10-01

F1 · security: Restricted stock award ("RSA") granted under the Issuer's 2015 Equity Compensation Plan (the "Plan") pursuant to the terms of the Executive Employment Agreement dated September 15, 2020, with an effective date of October 1, 2020 (the "Employment Agreement") by and between the Issuer and the Reporting Person. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2021 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

SEC source: 0001654954-20-010247 · section16.xml · derivative · entry 1

Elliott Mark S · CIK 0001309100 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2023-09-16

SEC source: 0001654954-20-009310 · section16.xml · nonDerivative · entry 1

Sellers Bakari T. · CIK 0001721556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,531